Dendritic cells as shepherds of T cell immunity in cancer
Immunity · 2023-10 · 56 (10) · 2218-2230
DOI: 10.1016/j.immuni.2023.08.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunity, 2023-10. Verfasst von Mikael J Pittet und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; Ludwig Institute for Cancer Research, Lausanne, Switzerland; AGORA…. Hauptthemen laut MEDLINE: Dendritic Cells, Neoplasms, T-Lymphocytes. Die Arbeit wurde bisher 338-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
In cancer patients, dendritic cells (DCs) in tumor-draining lymph nodes can present antigens to naive T cells in ways that break immunological tolerance. The clonally expanded progeny of primed T cells are further regulated by DCs at tumor sites. Intratumoral DCs can both provide survival signals to and drive effector differentiation of incoming T cells, thereby locally enhancing antitumor immunity; however, the paucity of intratumoral DCs or their expression of immunoregulatory molecules often limits antitumor T cell responses. Here, we review the current understanding of DC-T cell interactions at both priming and effector sites of immune responses. We place emerging insights into DC functions in tumor immunity in the context of DC development, ontogeny, and functions in other settings and propose that DCs control at least two T cell-associated checkpoints of the cancer immunity cycle. Our understanding of both checkpoints has implications for the development of new approaches to cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; Ludwig Institute for Cancer Research, Lausanne, Switzerland; AGORA Cancer Center, Swiss Cancer Center Leman, Lausanne, Switzerland; Depa…
- Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
- Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA 02115, USA.
- Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA 02115, USA; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA 021…
Förderung
- NCI NIH HHS
- NIAID NIH HHS
Zitieren
APA
Pittet, M. J., Di Pilato, M., Garris, C., & Mempel, T. R. (2023). Dendritic cells as shepherds of T cell immunity in cancer. Immunity, 56(10), 2218-2230. https://doi.org/10.1016/j.immuni.2023.08.014
Vancouver
Pittet MJ, Di Pilato M, Garris C, Mempel TR. Dendritic cells as shepherds of T cell immunity in cancer. Immunity. 2023;56(10):2218-2230. doi:10.1016/j.immuni.2023.08.014
BibTeX
@article{Pittet2023,
author = {Pittet, Mikael J and Di Pilato, Mauro and Garris, Christopher and Mempel, Thorsten R},
title = {Dendritic cells as shepherds of T cell immunity in cancer},
journal = {Immunity},
year = {2023},
volume = {56},
number = {10},
pages = {2218--2230},
doi = {10.1016/j.immuni.2023.08.014}
}
EUVIMED